 | • レポートコード：QFJ1-6012 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、小分子抗腫瘍標的薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（EGFR、ALK、Bcr-Abl、その他）、用途別市場規模（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・小分子抗腫瘍標的薬の市場動向 ・企業の競争状況、市場シェア ・小分子抗腫瘍標的薬の種類別市場規模と予測2016-2027（EGFR、ALK、Bcr-Abl、その他） ・小分子抗腫瘍標的薬の用途別市場規模と予測2016-2027（肝臓がん、結腸直腸がん、肺がん、胃がん、乳がん、食道がん、その他） ・小分子抗腫瘍標的薬の北米市場規模2016-2027（アメリカ、カナダ） ・小分子抗腫瘍標的薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・小分子抗腫瘍標的薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・小分子抗腫瘍標的薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・小分子抗腫瘍標的薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astrazeneca、Novartis、Millennium Pharmaceuticals、Bayer、Exelixis、Abbvie、Boehringer-Ingelheim、Eisai、Pfizer、Bristol-Myers Squibb、Roche、Bettapharma） ・結論 |
Market Analysis and Insights: Global Small Molecule Anti-tumor Targted Drug Market
The global Small Molecule Anti-tumor Targted Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Small Molecule Anti-tumor Targted Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Small Molecule Anti-tumor Targted Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Small Molecule Anti-tumor Targted Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Small Molecule Anti-tumor Targted Drug market.
Global Small Molecule Anti-tumor Targted Drug Scope and Market Size
Small Molecule Anti-tumor Targted Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Anti-tumor Targted Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
EGFR
ALK
Bcr-Abl
Others
Segment by Application
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 EGFR
1.2.3 ALK
1.2.4 Bcr-Abl
1.2.5 Others
1.3 Market by Application
1.3.1 Global Small Molecule Anti-tumor Targted Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Liver Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Gastric Cancer
1.3.6 Breast Cancer
1.3.7 Esophageal Cancer
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Anti-tumor Targted Drug Market Perspective (2016-2027)
2.2 Small Molecule Anti-tumor Targted Drug Growth Trends by Regions
2.2.1 Small Molecule Anti-tumor Targted Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Small Molecule Anti-tumor Targted Drug Historic Market Share by Regions (2016-2021)
2.2.3 Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Regions (2022-2027)
2.3 Small Molecule Anti-tumor Targted Drug Industry Dynamic
2.3.1 Small Molecule Anti-tumor Targted Drug Market Trends
2.3.2 Small Molecule Anti-tumor Targted Drug Market Drivers
2.3.3 Small Molecule Anti-tumor Targted Drug Market Challenges
2.3.4 Small Molecule Anti-tumor Targted Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Anti-tumor Targted Drug Players by Revenue
3.1.1 Global Top Small Molecule Anti-tumor Targted Drug Players by Revenue (2016-2021)
3.1.2 Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Players (2016-2021)
3.2 Global Small Molecule Anti-tumor Targted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Anti-tumor Targted Drug Revenue
3.4 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio
3.4.1 Global Small Molecule Anti-tumor Targted Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Anti-tumor Targted Drug Revenue in 2020
3.5 Small Molecule Anti-tumor Targted Drug Key Players Head office and Area Served
3.6 Key Players Small Molecule Anti-tumor Targted Drug Product Solution and Service
3.7 Date of Enter into Small Molecule Anti-tumor Targted Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Anti-tumor Targted Drug Breakdown Data by Type
4.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Type (2016-2021)
4.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2022-2027)
5 Small Molecule Anti-tumor Targted Drug Breakdown Data by Application
5.1 Global Small Molecule Anti-tumor Targted Drug Historic Market Size by Application (2016-2021)
5.2 Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Small Molecule Anti-tumor Targted Drug Market Size (2016-2027)
6.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type
6.2.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021)
6.2.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027)
6.2.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2027)
6.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Application
6.3.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021)
6.3.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027)
6.3.3 North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2027)
6.4 North America Small Molecule Anti-tumor Targted Drug Market Size by Country
6.4.1 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2016-2021)
6.4.2 North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Small Molecule Anti-tumor Targted Drug Market Size (2016-2027)
7.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type
7.2.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021)
7.2.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027)
7.2.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2027)
7.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application
7.3.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021)
7.3.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027)
7.3.3 Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2027)
7.4 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country
7.4.1 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2016-2021)
7.4.2 Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size (2016-2027)
8.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type
8.2.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application
8.3.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region
8.4.1 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size (2016-2027)
9.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type
9.2.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021)
9.2.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027)
9.2.3 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2027)
9.3 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application
9.3.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021)
9.3.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027)
9.3.3 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2027)
9.4 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country
9.4.1 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2016-2021)
9.4.2 Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size (2016-2027)
10.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type
10.2.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application
10.3.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country
10.4.1 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Details
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca Small Molecule Anti-tumor Targted Drug Introduction
11.1.4 Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.1.5 Astrazeneca Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Small Molecule Anti-tumor Targted Drug Introduction
11.2.4 Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Millennium Pharmaceuticals
11.3.1 Millennium Pharmaceuticals Company Details
11.3.2 Millennium Pharmaceuticals Business Overview
11.3.3 Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Introduction
11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.3.5 Millennium Pharmaceuticals Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Small Molecule Anti-tumor Targted Drug Introduction
11.4.4 Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Exelixis
11.5.1 Exelixis Company Details
11.5.2 Exelixis Business Overview
11.5.3 Exelixis Small Molecule Anti-tumor Targted Drug Introduction
11.5.4 Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.5.5 Exelixis Recent Development
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Small Molecule Anti-tumor Targted Drug Introduction
11.6.4 Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.6.5 Abbvie Recent Development
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Details
11.7.2 Boehringer-Ingelheim Business Overview
11.7.3 Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Introduction
11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.7.5 Boehringer-Ingelheim Recent Development
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Small Molecule Anti-tumor Targted Drug Introduction
11.8.4 Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.8.5 Eisai Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Small Molecule Anti-tumor Targted Drug Introduction
11.9.4 Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Introduction
11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.10.5 Bristol-Myers Squibb Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Small Molecule Anti-tumor Targted Drug Introduction
11.11.4 Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Bettapharma
11.12.1 Bettapharma Company Details
11.12.2 Bettapharma Business Overview
11.12.3 Bettapharma Small Molecule Anti-tumor Targted Drug Introduction
11.12.4 Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
11.12.5 Bettapharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Small Molecule Anti-tumor Targted Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of EGFR
Table 3. Key Players of ALK
Table 4. Key Players of Bcr-Abl
Table 5. Key Players of Others
Table 6. Global Small Molecule Anti-tumor Targted Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Small Molecule Anti-tumor Targted Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Small Molecule Anti-tumor Targted Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Small Molecule Anti-tumor Targted Drug Market Share by Regions (2016-2021)
Table 10. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Small Molecule Anti-tumor Targted Drug Market Share by Regions (2022-2027)
Table 12. Small Molecule Anti-tumor Targted Drug Market Trends
Table 13. Small Molecule Anti-tumor Targted Drug Market Drivers
Table 14. Small Molecule Anti-tumor Targted Drug Market Challenges
Table 15. Small Molecule Anti-tumor Targted Drug Market Restraints
Table 16. Global Small Molecule Anti-tumor Targted Drug Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Small Molecule Anti-tumor Targted Drug Market Share by Players (2016-2021)
Table 18. Global Top Small Molecule Anti-tumor Targted Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2020)
Table 19. Ranking of Global Top Small Molecule Anti-tumor Targted Drug Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Small Molecule Anti-tumor Targted Drug Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Small Molecule Anti-tumor Targted Drug Product Solution and Service
Table 23. Date of Enter into Small Molecule Anti-tumor Targted Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2016-2021)
Table 27. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Small Molecule Anti-tumor Targted Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2016-2021)
Table 31. Global Small Molecule Anti-tumor Targted Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Small Molecule Anti-tumor Targted Drug Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Small Molecule Anti-tumor Targted Drug Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Small Molecule Anti-tumor Targted Drug Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size by Country (2022-2027) & (US$ Million)
Table 63. Astrazeneca Company Details
Table 64. Astrazeneca Business Overview
Table 65. Astrazeneca Small Molecule Anti-tumor Targted Drug Product
Table 66. Astrazeneca Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 67. Astrazeneca Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Small Molecule Anti-tumor Targted Drug Product
Table 71. Novartis Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Millennium Pharmaceuticals Company Details
Table 74. Millennium Pharmaceuticals Business Overview
Table 75. Millennium Pharmaceuticals Small Molecule Anti-tumor Targted Drug Product
Table 76. Millennium Pharmaceuticals Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 77. Millennium Pharmaceuticals Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Small Molecule Anti-tumor Targted Drug Product
Table 81. Bayer Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Exelixis Company Details
Table 84. Exelixis Business Overview
Table 85. Exelixis Small Molecule Anti-tumor Targted Drug Product
Table 86. Exelixis Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 87. Exelixis Recent Development
Table 88. Abbvie Company Details
Table 89. Abbvie Business Overview
Table 90. Abbvie Small Molecule Anti-tumor Targted Drug Product
Table 91. Abbvie Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 92. Abbvie Recent Development
Table 93. Boehringer-Ingelheim Company Details
Table 94. Boehringer-Ingelheim Business Overview
Table 95. Boehringer-Ingelheim Small Molecule Anti-tumor Targted Drug Product
Table 96. Boehringer-Ingelheim Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 97. Boehringer-Ingelheim Recent Development
Table 98. Eisai Company Details
Table 99. Eisai Business Overview
Table 100. Eisai Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 101. Eisai Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Small Molecule Anti-tumor Targted Drug Product
Table 105. Pfizer Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Bristol-Myers Squibb Company Details
Table 108. Bristol-Myers Squibb Business Overview
Table 109. Bristol-Myers Squibb Small Molecule Anti-tumor Targted Drug Product
Table 110. Bristol-Myers Squibb Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 111. Bristol-Myers Squibb Recent Development
Table 112. Roche Company Details
Table 113. Roche Business Overview
Table 114. Roche Small Molecule Anti-tumor Targted Drug Product
Table 115. Roche Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 116. Roche Recent Development
Table 117. Bettapharma Company Details
Table 118. Bettapharma Business Overview
Table 119. Bettapharma Small Molecule Anti-tumor Targted Drug Product
Table 120. Bettapharma Revenue in Small Molecule Anti-tumor Targted Drug Business (2016-2021) & (US$ Million)
Table 121. Bettapharma Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Anti-tumor Targted Drug Market Share by Type: 2020 VS 2027
Figure 2. EGFR Features
Figure 3. ALK Features
Figure 4. Bcr-Abl Features
Figure 5. Others Features
Figure 6. Global Small Molecule Anti-tumor Targted Drug Market Share by Application: 2020 VS 2027
Figure 7. Liver Cancer Case Studies
Figure 8. Colorectal Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Gastric Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Esophageal Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Small Molecule Anti-tumor Targted Drug Report Years Considered
Figure 15. Global Small Molecule Anti-tumor Targted Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Small Molecule Anti-tumor Targted Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Small Molecule Anti-tumor Targted Drug Market Share by Regions: 2020 VS 2027
Figure 18. Global Small Molecule Anti-tumor Targted Drug Market Share by Regions (2022-2027)
Figure 19. Global Small Molecule Anti-tumor Targted Drug Market Share by Players in 2020
Figure 20. Global Top Small Molecule Anti-tumor Targted Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Anti-tumor Targted Drug as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Small Molecule Anti-tumor Targted Drug Revenue in 2020
Figure 22. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2016-2021)
Figure 23. Global Small Molecule Anti-tumor Targted Drug Revenue Market Share by Type (2022-2027)
Figure 24. North America Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Small Molecule Anti-tumor Targted Drug Market Share by Type (2016-2027)
Figure 26. North America Small Molecule Anti-tumor Targted Drug Market Share by Application (2016-2027)
Figure 27. North America Small Molecule Anti-tumor Targted Drug Market Share by Country (2016-2027)
Figure 28. United States Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Small Molecule Anti-tumor Targted Drug Market Share by Type (2016-2027)
Figure 32. Europe Small Molecule Anti-tumor Targted Drug Market Share by Application (2016-2027)
Figure 33. Europe Small Molecule Anti-tumor Targted Drug Market Share by Country (2016-2027)
Figure 34. Germany Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Small Molecule Anti-tumor Targted Drug Market Share by Region (2016-2027)
Figure 44. China Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Small Molecule Anti-tumor Targted Drug Market Share by Type (2016-2027)
Figure 52. Latin America Small Molecule Anti-tumor Targted Drug Market Share by Application (2016-2027)
Figure 53. Latin America Small Molecule Anti-tumor Targted Drug Market Share by Country (2016-2027)
Figure 54. Mexico Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Small Molecule Anti-tumor Targted Drug Market Share by Country (2016-2027)
Figure 60. Turkey Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Small Molecule Anti-tumor Targted Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Astrazeneca Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 65. Millennium Pharmaceuticals Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 66. Bayer Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 67. Exelixis Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 68. Abbvie Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 69. Boehringer-Ingelheim Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 70. Eisai Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 72. Bristol-Myers Squibb Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 73. Roche Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 74. Bettapharma Revenue Growth Rate in Small Molecule Anti-tumor Targted Drug Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
世界の小分子標的抗がん剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targeted Anti-cancer Drug Market The global Small Molecule Targeted Anti-cancer Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…- 世界の小分子標的薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Small Molecule Targted Drug Market The global Small Molecule Targted Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 小分子がん治療薬のグローバル市場調査 2019年 The global Small Molecule Cancer Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Small Molecule Cancer Drug volume and value at global level, regional level and company level. From a global per…
- 小分子がん治療薬のグローバル市場調査 2019年 The global Small Molecule Cancer Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Small Molecule Cancer Drug volume and value at global level, regional level and company level. From a global per…
- 世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年） Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drug…